Segment Information (Tables)

12 Months Ended

Dec. 31, 2023

Schedule of Segment Reporting Information, by Segment

The following table summarizes select operating results for each reportable segment (in millions).


	Successor						Predecessor
(In millions)	For Year Ended December 31, 2023		For Year Ended December 31, 2022		From October 20, 2021 through December 31, 2021		From July 1, 2021 through October 19, 2021		For Year Ended June 30. 2021
Revenues
Medical	$	284.5	$	271.7	$	49.2	$	60.3	$	155.7
Technologies	516.4		446.1		104.9		107.7		455.9
Consolidated Revenues	$	800.9	$	717.8	$	154.1	$	168.0	$	611.6
Segment Income (Loss) from Operations
Medical	$	13.0	$	(98.9)	$	(5.4)	$	(1.8)	$	2.3
Technologies	46.0		(103.1)		(0.8)		8.2		68.1
Total Segment Income (Loss) from Operations	59.0		(202.0)		(6.2)		6.4		70.4
Corporate and other	(80.9)		(95.8)		(16.7)		(48.0)		(59.2)
Consolidated (Loss) Income from Operations	$	(21.9)	$	(297.8)	$	(22.9)	$	(41.6)	$	11.2
Capital Expenditures
Medical	$	21.8	$	22.6	$	3.8	$	6.8	$	14.2
Technologies	18.0		11.6		2.0		2.7		12.2
Total operating and reportable segments	39.8		34.2		5.8		9.5		26.4
Corporate and other	1.0		0.4		0.3		0.3		—
Total Capital Expenditures	$	40.8	$	34.6	$	6.1	$	9.8	$	26.4
Depreciation and Amortization
Medical	$	75.2	$	82.4	$	17.0	$	13.3	$	33.3
Technologies	86.9		91.1		20.1		12.4		49.7
Total operating and reportable segments	162.1		173.5		37.1		25.7		83.0
Corporate and other	0.7		1.0		0.2		0.2		0.6
Total Depreciation and Amortization	$	162.8	$	174.5	$	37.3	$	25.9	$	83.6

Revenue from External Customers by Geographic Areas

The following details revenues by geographic region. Revenues generated from external customers are attributed to geographic regions through sales from site locations (i.e., point of origin) (in millions).


	Revenues
	Successor						Predecessor
	Fiscal Year Ended December 31,		Fiscal Year Ended December 31,		From October 20, 2021 through December 31		From July 1, 2021 through October 19,		For the Fiscal Year Ended June 30,
	2023		2022		2021		2021		2021
North America
Medical	$	258.1	$	252.0	$	45.3	$	54.6	$	138.6
Technologies	254.2		210.7		47.6		53.4		199.4
Total North America	512.3		462.7		92.9		108.0		338.0
Europe
Medical	26.4		19.7		3.9		5.7		17.1
Technologies	245.7		222.1		55.3		52.6		241.5
Total Europe	272.1		241.8		59.2		58.3		258.6
Asia Pacific
Medical	—		—		—		—		—
Technologies	16.5		13.3		2.0		1.7		15.0
Total Asia Pacific	16.5		13.3		2.0		1.7		15.0
Total Revenues	$	800.9	$	717.8	$	154.1	$	168.0	$	611.6

Schedule of Revenue by Timing of Recognition

The following details revenues by timing of recognition (in millions):


	Revenues
	Successor						Predecessor
	Fiscal Year Ended December 31,		Fiscal Year Ended December 31,		From October 20, 2021 through December 31		From July 1, 2021 through October 19,		For the Fiscal Year Ended June 30,
			2022		2021		2021		2021
Point in time	$	496.0	$	485.9	$	120.1	$	123.6	$	456.6
Over time	304.9		231.9		34.0		44.4		155.0
Total revenues	$	800.9	$	717.8	$	154.1	$	168.0	$	611.6

Revenue from External Customers by Products and Services

The following details revenues by product category (in millions):


	Revenues
	Successor						Predecessor
	Fiscal Year Ended December 31,		Fiscal Year Ended December 31,		From October 20, 2021 through December 31		From July 1, 2021 through October 19,		For the Fiscal Year Ended June 30,
	2023		2022		2021		2021		2021
Medical segment:
Medical	$	284.5	$	271.7	$	49.2	$	60.3	$	155.7
Technologies segment:
Reactor Safety and Control Systems	204.0		163.8		30.6		34.7		146.8
Radiological Search, Measurement, and Analysis Systems	312.4		282.3		74.3		73.0		309.1
Total Revenues	$	800.9	$	717.8	$	154.1	$	168.0	$	611.6

Schedule of Property, Plant, and Equipment by Geographical Areas

The following details property, plant, and equipment, net, by geography (in millions):


	Property, Plant, and Equipment, Net
(In millions)	As of December 31, 2023		As of December 31, 2022
North America	$	82.9	$	79.4
Europe	51.5		44.7
Asia Pacific	0.1		0.2
Total	$	134.5	$	124.3